P1129: ACALABRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL): RESULTS OF A PHASE 2, MULTICENTER, OPEN-LABEL TRIAL. (23rd June 2022) - Strati, P.; Coleman, M.; Stevens, D.; Ma, S.; Patti, C.; Levy, M.; Lossos, I. S.; Ramakrishnan Geethakumari, P.; Lam, S.; Calvo, R.; Higgins, K.; Budde, L.